Eileen Donovan

Papers

Total Citations

H-Index

About

Eileen Donovan is a surgical oncologist whose research focuses on advancing the safety and efficacy of minimally invasive pancreatic surgery, particularly robotic pancreaticoduodenectomy. Her most cited work, "Defining the operative time threshold for safety in patients undergoing robotic pancreaticoduodenectomy" (2023), established a critical benchmark for operative duration, demonstrating that prolonged surgery correlates with increased complications. This study, with 4 citations, provides actionable guidelines for surgeons to optimize patient outcomes by balancing technical precision with time efficiency. Donovan’s contributions are pivotal in refining robotic surgical protocols, reducing morbidity, and expanding access to complex procedures. Her research underscores a commitment to evidence-based practice, directly impacting clinical decision-making in high-stakes hepatobiliary surgery. As a rising voice in surgical oncology, Donovan’s work bridges the gap between technological innovation and patient safety, offering a framework for future studies on operative thresholds and risk stratification. Her findings are essential reading for trainees and practitioners navigating the evolving landscape of robotic surgery.